Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 76 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 03/20/21
End: 08/01/21
Due: 08/01/22
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra
Phase: N/A
Priority: Normal
Start: 02/02/22
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 01/31/21
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 01/31/21
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 10/11/19
End: 12/18/20
Due: 12/18/21
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 11/10/20
Due: 11/10/21
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 11/01/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 10/31/25
End: 02/28/29
Due: 02/28/30
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 09/04/18
End: 03/30/20
Due: 03/30/21
Phase: N/A
Priority: Normal
Start: 08/14/18
End: 03/30/19
Due: 03/30/20
Phase: N/A
Priority: Normal
Start: 08/27/21
End: 05/18/22
Due: 05/18/23
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 04/30/16
Due: 04/30/17